Beth Ashbridge Ph.D.

Beth Ashbridge Ph.D.

Goodwin

Contact
View Bio
RSS

Latest Posts › Biopharmaceutical

Share:

German Court Invalidates CureVac Patent in Ongoing BioNTech Lawsuit

On December 19, a German court invalidated CureVac’s messenger RNA technology patent, EP 1 857 122 B1, in a lawsuit brought by CureVac against its rival BioNTech...more

12/28/2023  /  Biopharmaceutical , Biotechnology , Life Sciences , Patent Invalidity , Patents , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide